VSTM Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
40.1M
+114.7%
18.7M
+6.5%
17.5M
+56.0%
11.2M
+426.1%
2.1M
Cost of Revenue
4.0M
+32.4%
3.1M
+16.8%
2.6M
+56.4%
1.7M
+274.4%
446.0K
Gross Profit
36.0M
+130.7%
15.6M
+4.7%
14.9M
+55.9%
9.6M
+466.1%
1.7M
Operating Expenses
68.7M
+13.6%
60.5M
+7.3%
56.4M
+12.2%
50.3M
+10.6%
45.5M
R&D
41.3M
+8.2%
38.2M
+20.7%
31.7M
+9.3%
29.0M
+17.0%
24.8M
SG&A
27.4M
+22.9%
22.3M
-8.8%
24.4M
+16.4%
21.0M
+1.6%
20.7M
Operating Income
-32710000
+27.1%
-44897000
-8.3%
-41475000
-1.9%
-40715000
+7.0%
-43764000
EBITDA
-32430000
+27.3%
-44618000
-9.5%
-40759000
+0.2%
-40841000
+6.4%
-43636000
Net Income
-34673000
+5.2%
-36591000
-11.2%
-32916000
+66.6%
-98518000
-279.9%
-25934000
EPS (Basic)
$-0.35
+5.4%
$-0.37
+5.1%
$-0.39
+71.1%
$-1.35
-246.2%
$-0.39
EPS (Diluted)
$-0.35
+23.9%
$-0.46
-7.0%
$-0.43
+68.1%
$-1.35
-117.7%
$-0.62
Shares (Diluted)
100.1M
+1.0%
99.1M
+30.7%
75.9M
+3.7%
73.2M
-1.2%
74.0M
Verastem (VSTM) โ€” Financials